Dyrk1A-IN-13 (Compound 1) is a DYRK1A inhibitor with an IC50 of 41 nM. It reduces LPS-induced nitric oxide production and exhibits antioxidant and anti-inflammatory properties. Dyrk1A-IN-13 is applicable in research related to Alzheimers disease, cancer, and diabetes.
Target:
NO Synthase|||DYRK
* VAT and and shipping costs not included. Errors and price changes excepted
